According to a CDC report from August 2025, 26.5% of adults with diagnosed diabetes used GLP-1 injectables in 2024
Results: Primary outcome: Semaglutide reduced the amount of alcohol consumed (p=0.01) and the peak breath alcohol concentration (p=0.03) in the self-administration test, with an effect size that was deemed medium to large
A lack of glutathione in the body can lead to oxidative stress that can cause various health problems like diabetes, arthritis, and cancer
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Tirzepatide and semaglutide are GLP-1 medications available for weight loss under the brand names Zepbound and Wegovy
Yet even in the pivotal STEP-1 study, 14 % of participants on semaglutide lost 8 weeks
Ozempic and Wegovy are brand names for the same medication, semaglutide, and work the same way in your body by mimicking the effects of a natural hormone called glucagon-like peptide -1 (GLP-1)